ABCL
AbCellera Biologics Inc. Common Shares
$3.79
-3.90%
-0.16
Notify me if price changes either direction
Buy ABCL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.2B
Enterprise value
840.4M
Trailing PE
-6.8818181818182
Forward PE
-6.0757575
PEG Ratio
-0.58495454545455
Enterprise to EBITDA
-3.612
Enterprise to revenue
23.791
Price to book MRQ
1.2437966
Price to sales TTM
33.979717
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
35.3M
EBITDA
-232664000
Diluted EPS TTM
-0.57
Total Cash (MRQ)
495.7M
Current ratio (MRQ)
10.103
Operating Cash Flow (TTM)
-104552000
ABCL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
